Inscrivez-vous 01 49 36 46 20
appel-offre
appel-offre
 
            
Date de publication : 13/01/2022
Date de péremption :
Type de procédure : Négociée sans mise en concurrence
Type de document : Avis en cas de transparence ex ante volontaire
NORVÈGE
appel-offre

NorvËge-Vads¯: RÈactifs de laboratoire

2022/S 9-016716  (Source TED)
 
 
V  E  R  S  I  O  N      F  R  A  N  C  A  I  S  E
TX:
13/01/2022 S9 NorvËge-Vads¯: RÈactifs de laboratoire 2022/S 009-016716 Avis en cas de transparence ex ante volontaire Fournitures
 
 
Section I: Pouvoir adjudicateur/entitÈ adjudicatrice
I.1) Nom et adresses Nom officiel: SYKEHUSINNKJÿP HF NumÈro national d'identification: 916879067 Adresse postale: Postboks 40 Ville: VADSÿ Code NUTS: NO Norge Code postal: 9811 Pays: NorvËge Point(s) de contact: Postmottak Sykehusinnkj¯p Courriel: post@sykehusinnkjop.no TÈlÈphone: +47 78950700 Adresse(s) internet:
Adresse principale: https://permalink.mercell.com/170503510.aspx Adresse du profil díacheteur: http://www.sykehusinnkjop.no/
I.4) Type de pouvoir adjudicateur Organisme de droit public
I.5) ActivitÈ principale SantÈ
 
 
Section II: Objet
II.1) ...tendue du marchÈ
II.1.1) IntitulÈ:
Voluntary ex-ante transparency notice: Next generation sequencing kit for HLA typing NumÈro de rÈfÈrence: 2021/730
II.1.2) Code CPV principal 33696500 RÈactifs de laboratoire
II.1.3) Type de marchÈ Fournitures
II.1.4) Description succincte:
Oslo University Hospital Trust intends to enter into a framework agreement with Genome Products BV for the delivery of NGSgo kits with the accompanying software for HLA typing. The contract will be entered into as a procurement without a contest in accordance with the Public Procurement Regulations, section 13-4 letter b). Oslo University Hospital Trust aims to sign a contract shortly after the deadline stated in the Public Procurement Regulations, section 25-3 of ten days after publication of this announcement has expired.
II.1.6) Information sur les lots Ce marchÈ est divisÈ en lots: non
II.1.7) Valeur totale du marchÈ (hors TVA) Valeur hors TVA: 24 000 000.00 NOK
II.2) Description
II.2.2) Code(s) CPV additionnel(s) 33000000 MatÈriels mÈdicaux, pharmaceutiques et produits de soins personnels 38000000 ...quipements de laboratoire, d'optique et de prÈcision (exceptÈ les lunettes)
II.2.3) Lieu d'exÈcution Code NUTS: NO081 Oslo
II.2.4) Description des prestations:
HLA typing is used when assessing transplants for critically ill patients who require bone marrow, and for other transplant matching. The analysis results must be transferred electronically from the analysis software to the laboratory computer system Orpheus. Such connection and installation is necessary in order to minimise the risk of wrong diagnostics. After an open tender contest in 2015/2016, a contract was signed with Genome Products BV and its analysis software was connected to Orpheus. The connection to Orpheus was specially adapted for the current analysis software. Any change would lead to an unacceptable risk that the adaptations required in Orpheus cannot be done either technically, or within a reasonable implementation period. Therefore a necessary requirement for NGS HLA typing kits is that they can be analysed with the analysis software from Genome Products BV.
II.2.5) CritËres díattribution
II.2.11) Information sur les options Options: oui Description des options:
The option for an annual extension for as long as the department uses the Orpheus laboratory system, and the challenges involved in changing the analysis programme are the same.
II.2.13) Information sur les fonds de l'Union europÈenne
Le contrat s'inscrit dans un projet/programme financÈ par des fonds de l'Union europÈenne: non
II.2.14) Informations complÈmentaires Comments concerning the value stated in point II.1.7: The procurement and the annual value of the contract are approx. NOK 4 million. The contract duration is one year, with an option for an annual extension for maximum five times. I.e., a maximum length of six years.
 
 
Section IV: ProcÈdure
IV.1) Description
IV.1.1) Type de procÈdure ProcÈdure nÈgociÈe sans publication prÈalable Explication:
Genome Products BV currently have a monopoly on the sale/delivery of NGSgo and GenDx products with the accompanying analysis software. HLA typing is used when assessing transplants for critically ill patients who require bone marrow, and for other transplant matching. The analysis results must be transferred electronically from the analysis software to the laboratory computer system Orpheus. The connection to Orpheus was specially adapted for the current analysis software. Any change would lead to an unacceptable risk that the adaptations required in Orpheus cannot be done either technically, or within a reasonable implementation period. It is unrealistic that the necessary connections and installations of the required analysis programme will be ready for use within a reasonable period from the award of any new contract. Such connections and installation are, at the same time, an essential requirement for the department being able to use any new HLA typing kits. Therefore a necessary requirement for NGS HLA typing kits is that they can be analysed with the analysis software from Genome Products BV.
IV.1.3) Information sur l'accord-cadre
Le marchÈ implique la mise en place d'un accord-cadre
IV.1.8) Information concernant líaccord sur les marchÈs publics (AMP)
Le marchÈ est couvert par l'accord sur les marchÈs publics: oui
IV.2) Renseignements d'ordre administratif
 
 
Section V: Attribution du marchÈ/de la concession
MarchÈ n : 20151593000 IntitulÈ:
Next generation sequencing kit for HLA-typing.
V.2) Attribution du marchÈ/de la concession
V.2.1) Date d'attribution du marchÈ:
10/12/2021
V.2.2) Informations sur les offres
Le marchÈ a ÈtÈ attribuÈ un groupement d'opÈrateurs Èconomiques: non
V.2.3) Nom et adresse du titulaire/concessionnaire Nom officiel: Genome Products BV Ville: Utrecht Code NUTS: NL31 Utrecht Pays: Pays-Bas
Le titulaire/concessionnaire sera une PME: non
V.2.4) Informations sur le montant du marchÈ/du lot/de la concession (hors TVA) Valeur totale du marchÈ/du lot/de la concession: 24 000 000.00 NOK
V.2.5) Information sur la sous-traitance
 
 
Section VI: Renseignements complÈmentaires
VI.3) Informations complÈmentaires:
VI.4) ProcÈdures de recours
VI.4.1) Instance chargÈe des procÈdures de recours Nom officiel: ÿst-Finnmark tingrett Adresse postale: Postboks 54 Ville: Vads¯ Code postal: 9811 Pays: NorvËge Courriel: ost-finnmark.tingrett@domstol.no
VI.4.2) Organe chargÈ des procÈdures de mÈdiation Nom officiel: Klageorgan for offentlige anskaffelser Adresse postale: Postboks 439 Sentrum Ville: Bergen Code postal: 5805 Pays: NorvËge Courriel: postmottak@kofa.no TÈlÈphone: +47 55597500 Fax: +47 55597599 Adresse internet: www.kofa.no
VI.4.4) Service auprËs duquel des renseignements peuvent Ítre obtenus sur l'introduction de recours Nom officiel: Sykehusinnkj¯p HF Adresse postale: Postboks 40 Ville: Vads¯ Code postal: 9811 Pays: NorvËge Courriel: post@sykehusinnkjop.no
VI.5) Date díenvoi du prÈsent avis:
08/01/2022 NorvËge-Vads¯: RÈactifs de laboratoireType díacheteur: Organisme de droit publicType díavis: Avis en cas de transparence ex ante volontaireType de procÈdure: ProcÈdure nÈgociÈe sans mise en concurrenceType de marchÈ: Fournitures 13/01/2022 NO National
 
 
C L A S S E    C P V
33000000 - Matériels médicaux, pharmaceutiques et produits de soins personnnels 
33696500 - Réactifs de laboratoire 
38000000 - Équipements de laboratoire, d'optique et de précision (excepté les lunettes)